Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2 is a research paper published in Blood Advances (2022). On theSindex it has a DataRank of 1.1. It has been cited 40 times, with 31 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.557
From this paper's citation signal
Citation Network Contribution
0.524
From 21 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 31 citers.
NCI NIH HHS
Grant: P30 CA008748
National Institute for Health Research (NIHR)
Grant: NIHR200257
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals